• LDH Cytotoxicity Assay Kit for Nanomaterial Safety

  2026-09-17

  Translate membrane damage into a quantitative, non-radioactive endpoint for nanomaterial screening, cancer research, and disease-model studies. The LDH Cytotoxicity Assay Kit pairs a practical 490 nm readout with controls that help distinguish genuine toxicity from interference caused by magnetite-containing formulations.

• CHIR 99021 trihydrochloride: Reliable Cell Assays

  2026-09-17

  This scenario-based guide explains how CHIR 99021 trihydrochloride, SKU B5779, can improve experimental planning for viability, proliferation, cytotoxicity, and organoid workflows. It connects GSK-3 biology with practical controls, dose selection, formulation, interpretation, and vendor-reliability decisions.

• Bacitracin (B1670): Practical Research Guide

  2026-09-16

  Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis. This guide covers solvent selection, preparation, QC, and troubleshooting, while defining boundaries for work that is not diagnostic, clinical, or medical.

• RepSox for iPSC Platelet Differentiation

  2026-09-16

  RepSox offers a defined ALK5 inhibition variable for induced pluripotent stem cell reprogramming and differentiation research. This guide connects its established TGF-β biology with an optimized hiPSC-to-platelet workflow while clearly separating published findings from testable protocol adaptations.

• ATRNL1 and Atrial Fibrillation: Single-Nuclei Insights

  2026-09-15

  This reference study applies large-scale single-nucleus RNA sequencing to human left atrial tissue and identifies cardiomyocyte- and macrophage-specific transcriptional changes associated with atrial fibrillation. Functional perturbation experiments nominate ATRNL1 as a regulator of cellular stress responses and cardiac electrical behavior, providing a cell-resolved framework for studying AF mechanisms.

• A40926 Workflows for Glycopeptide Research

  2026-09-15

  A40926 is a mechanistically defined glycopeptide antibiotic and dalbavancin precursor for studying cell-wall inhibition, resistant Gram-positive pathogens, and Neisseria gonorrhoeae. This practical guide connects MIC testing, pathway-focused experiments, and troubleshooting strategies to improve assay reproducibility.

• Hexamethonium Bromide in Causal Autonomic Studies

  2026-09-14

  Hexamethonium Bromide enables functional dissection of ganglionic nicotinic signaling in cardiovascular and neuronal research. This article develops a causal assay framework from conscious-mouse hypertension data, emphasizing interpretation, controls, and reproducible product handling.

• RNASEH1-AS1 in Hepatocellular Carcinoma

  2026-09-14

  The reference study integrates TCGA-based transcriptomics, prognostic modeling, immune-infiltration analysis, and cellular validation to position RNASEH1-AS1 as a candidate biomarker and oncogenic regulator in hepatocellular carcinoma. Its findings provide a framework for connecting lncRNA expression with clinical risk, pathway activity, and experimentally testable tumor phenotypes.

• Indomethacin Sodium: A Mechanism-Aware Assay Guide

  2026-09-13

  Indometacin Sodium can support more than a conventional COX inhibition experiment. This mechanism-aware guide connects prostaglandin biology with Wnt/β-catenin-dependent oligodendrocyte differentiation while showing how to separate inflammatory, cytotoxic, and remyelination readouts.

• DNM3OS–miR-454-3p Signaling in Cervical Cancer

  2026-09-12

  The 2026 Molecular Biology Reports study identifies DNM3OS as a potentially protective lncRNA in cervical cancer and connects its loss to tumor growth, invasion, epithelial–mesenchymal transition, and unfavorable progression-free survival. Through expression profiling, cellular perturbation, binding analysis, and rescue experiments, the authors position the DNM3OS–miR-454-3p relationship as a mechanistic and prognostic framework for further cervical cancer research.

• HyperFluor™ 488 Goat Anti-Mouse IgG: Lab Guide

  2026-09-12

  This scenario-driven guide explains how HyperFluor™ 488 Goat Anti-Mouse IgG (H+L) Antibody, SKU K1204, can support controlled immunofluorescence, flow cytometry, and western blot workflows alongside viability, proliferation, and cytotoxicity assays. It emphasizes assay controls, storage, compatibility, signal interpretation, and practical vendor selection.

• Dynamic Atrial Slow Conduction in Persistent AF

  2026-09-11

  Lange et al. show that premature stimulation in persistent atrial fibrillation expands pre-existing slow-conduction regions rather than mainly generating new regions. The finding, established through directional optical mapping in goats, highlights a dynamic and state-dependent component of the arrhythmogenic substrate that may improve interpretation of conduction maps and experimental treatment strategies.

• CD109, STAT3, and Chemoresistance in Colorectal Cancer

  2026-09-11

  A 2026 study identifies CD109 as a central regulator of colorectal cancer stemness, chemoresistance, and metastatic colonization. Its mechanistic model connects CD109 with LRRC8A, AKAP12, PKCα, STAT3, and WNT signaling, providing a framework for testing pathway-directed strategies in advanced disease.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-10

  This 2025 study develops gastric cancer assembloids by combining patient-matched tumor organoids with separately expanded stromal cell subpopulations. The model preserves tumor–stroma interactions that alter gene expression and drug sensitivity, creating a more informative platform for resistance studies and personalized treatment evaluation.

• YAP–TEAD Super-Enhancers in Surface Ectoderm

  2026-09-10

  Wang et al. define a super-enhancer landscape that helps establish early surface ectoderm identity from pluripotent stem cells and identify YAP–TEAD as an upstream regulator of this process. By integrating chromatin architecture, enhancer perturbation, and transcription-factor analysis, the study connects regulatory DNA organization with lineage commitment and epithelial regeneration research.

7907 records 1/528 page Next 12345 下5页 Last page